Yervoy (ipilimumab) - BMS
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) (clinicaltrials.gov) - Oct 15, 2026 - P2 | N=35 | Recruiting | Sponsor: Mark Bernard | Not yet recruiting ➔ Recruiting 
Enrollment open • Cervical Cancer • Esophageal Cancer • Esophageal Squamous Cell Carcinoma • Gastric Cancer • Gastroesophageal Cancer • Head and Neck Cancer • Lung Cancer • Lung Non-Small Cell Squamous Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • ALK • EGFR • PD-L1
http://clinicaltrials.gov/ct2/show/NCT07770100
 
Oct 15, 2026
 
Prev Next